Skip to main content

Merit Medical Systems, Inc.

corporate_fare Company Profile

Merit Medical Systems, Inc.

MMSI·NASDAQ·Industrial Applications And Services·CIK 0000856982

Merit Medical Systems, Inc. is a manufacturer and marketer of medical devices used in interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company was founded in 1987 by Fred P. Lampropoulos, Kent W. Stanger, Darla Gill, and William Padilla. Initially, operations focused on injection and insert molding of plastics, with the first product being a specialized control syringe for injecting contrast solution during cardiac angiograms. Since then, the product lines have expanded through internal research and development and strategic acquisitions. The business strategy focuses on enhancing global growth and profitability through research and development, sales model optimization, cost discipline, and operational focus; optimizing operational capability through lean processes, cost-effective environments, and asset utilization; targeting high-growth, high-return opportunities in core divisions; maintaining a disciplined, customer-focused enterprise to address unmet or underserved healthcare needs globally; and creating a sustainable business. The company operates through domestic and foreign subsidiaries and representative offices. Its principal offices are located at 1600 West Merit Parkway, South Jordan, Utah, 84095.

Merit Medical Systems, Inc. (NASDAQ:MMSI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for MMSI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for MMSI spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Merit 10-Q Fills In Q3: $42.3M Net Income, $175.2M Nine-Month Cash Flow, $5.1M Note Penalty
  • Merit Beats Q3, Raises 2026 EPS Guidance, Discloses $45M Solo Pace Buy
  • Merit Medical Beats High End of Expectations, Raises 2026 Revenue and EPS Guidance
  • Merit Medical Q2 Earnings Beat Consensus; View Point Acquisition and DualCap Divestiture Reshape Portfolio
  • Merit Medical Beats Q2 EPS by 24%, Lifts 2026 Guidance Above Consensus

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.52B
Net Income
$128.49M
Diluted EPS
$2.13
Op. Cash Flow
$297.37M
Free Cash Flow
$215.66M
Gross Profit
$738.27M
Operating Income
$184.72M
Cash & Equivalents
$446.4M
Total Debt
$734.04M
Debt / Equity
0.46×
Net Margin
8.5%
Shares Outstanding
59.42M sh
Source: 10-K · filed 2026-02-24 · accession 0000856982-26-000008

Short Interest & Short Volume

5.11 days to cover

FINRA reported short interest of 3,997,363 shares in MMSI as of the October 30, 2026 settlement, a 5.4% increase from the prior period — about 5.1 days to cover at its recent average daily volume. On November 19, 2026, 57.4% of MMSI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,997,363 shares as of October 30, 2026
Change vs prior period▲ 5.4%
Days to cover5.11 at avg daily volume of 782,874
Daily short volume (FINRA facilities)57.4% of 233,970 shares on November 19, 2026
5-day average short volume60.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$84.41
52-week range · as of 2026-10-29 $59.74 – $94.85
Market cap
$5.06B
Volume
579.4K (0.8× avg)
3-mo avg 720.7K
Live data · 2026-11-20 13:13 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed MMSI - Latest Insights

MMSI
Oct 29, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $93.39
Real-time Price: $84.41 info
Change: -$8.98 (-10%) info
Market Cap: $5.057B info
MMSI
Oct 29, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $93.39
Real-time Price: $84.41 info
Change: -$8.98 (-10%) info
Market Cap: $5.057B info
MMSI
Oct 29, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $93.39
Real-time Price: $84.41 info
Change: -$8.98 (-10%) info
Market Cap: $5.057B info
MMSI
Jul 30, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $87.03
Real-time Price: $84.41 info
Change: -$2.62 (-3%) info
Market Cap: $5.057B info
MMSI
Jul 30, 2026, 4:30 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $83.35
Real-time Price: $84.41 info
Change: +$1.06 (+1%) info
Market Cap: $5.057B info
MMSI
May 19, 2026, 4:54 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $63.77
Real-time Price: $84.41 info
Change: +$20.64 (+32%) info
Market Cap: $5.057B info
MMSI
Apr 30, 2026, 4:58 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $68.18
Real-time Price: $84.41 info
Change: +$16.23 (+24%) info
Market Cap: $5.057B info
MMSI
Apr 01, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $68.23
Real-time Price: $84.41 info
Change: +$16.18 (+24%) info
Market Cap: $5.057B info
MMSI
Apr 01, 2026, 9:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $70.50
Real-time Price: $84.41 info
Change: +$13.91 (+20%) info
Market Cap: $5.057B info
MMSI
Mar 31, 2026, 4:22 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $68.93
Real-time Price: $84.41 info
Change: +$15.48 (+22%) info
Market Cap: $5.057B info
MMSI
Mar 24, 2026, 8:33 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $68.13
Real-time Price: $84.41 info
Change: +$16.28 (+24%) info
Market Cap: $5.057B info
MMSI
Feb 24, 2026, 4:32 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $85.49
Real-time Price: $84.41 info
Change: -$1.08 (-1%) info
Market Cap: $5.057B info
MMSI
Feb 24, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $85.49
Real-time Price: $84.41 info
Change: -$1.08 (-1%) info
Market Cap: $5.057B info
MMSI
Jan 08, 2026, 4:33 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $93.18
Real-time Price: $84.41 info
Change: -$8.77 (-9%) info
Market Cap: $5.057B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets